References
- Vasin AV , TemkinaOA, EgorovVV, KlotchenkoSA, PlotnikovaMA, KiselevOI. Molecular mechanism enhancing the proteome of influenza A viruses: an overwiew of recently discovered proteins. Virus Res.185, 53–63 (2014).
- Palese P , ShawML. Orthomyxoviridae: the viruses and their replication. In : Fields Virology (Volume 2). KnipeDM, HowleyP ( Eds). Lippincott Williams & Wilkins, PA, USA, 1691–1740 (2013).
- Lee SM , YenHL. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Res.96 (3), 391–404 (2012).
- Saladino R , BarontiniM, CrucianelliM, NencioniL, SgarbantiR, PalamaraAT. Current advances in anti-influenza therapy. Curr. Med. Chem.17 (20), 2101–2140 (2010).
- Sgarbanti R , NencioniL, AmatoreDet al. Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy. Antioxid. Redox Signal.15 (3), 593–606 (2011).
- Nencioni L , De ChiaraG, SgarbantiRet al. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J. Biol. Chem.284 (23), 16004–16015 (2009).
- Palamara AT , NencioniL, AquilanoKet al. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis.191 (10), 1719–1729 (2005).
- Yang XJ , SetoE. Lysine acetylation: codified crosstalk with other posttraslational modifications. Mol. Cell31 (4), 449–461 (2008).
- Falkenberg KJ , JohnstoneRW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov.13 (9), 673–691 (2014).
- Clocchiatti A , FloreanC, BrancoliniC. Class IIa HDACs: from important roles in differentiation to possible implications in tumorigenesis. J. Cell. Mol. Med.15 (9), 1833–1846 (2011).
- Yang PH , ZhangL, ZhangYJ, ZhangJ, XuWF. HDAC6: physiological function and its selective inhibitors for cancer treatment. Drug Discov. Ther.7 (6), 233–242 (2013).
- Yan J . Interplay between HDAC6 and its interacting partners: essential roles in the aggresome–autophagy pathway and neurodegenerative diseases. DNA Cell Biol.33 (9), 567–580 (2014).
- Rotili D , SimonettiG, SavarinoA, PalamaraAT, MigliaccioAR, MaiA. Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathies. Curr. Top. Med. Chem.9 (3), 272–291 (2009).
- Das Gupa K , ShakespearMR, IyerA, FairlieDP, SweetMJ. Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for infiammatory and infectious diseases. Clin. Transl. Immunol.5 (1), e62 (2016).
- Savarino A , MaiA, NorelliSet al. ‘Shock and kill’ effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence. Retrovirology6, 52 (2009).
- Guise AJ , BudayevaHG, DinerBA, CristeaIM. Histone deacetylases in herpesvirus replication and virus-stimulated host defense. J. Viruses5 (7), 1607–1632 (2013).
- Yamauchi Y , BoukariH, BanerjeeI, SbalzariniIF, HorvathP, HeleniusA. Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry. PLoS Pathog.7 (10), e1002316 (2011).
- Banerjee I , MiyakeY, NobsSPet al. Influenza A virus uses the aggresome processing machinery for host cell entry. Science346 (6208), 473–477 (2014).
- Husain M , HarrodKS. Influenza A virus-induced caspase-3 cleaves the histone deacetylase 6 in infected epithelial cells. FEBS Lett.583 (15), 2517–2520 (2009).
- Husain M , HarrodKS. Enhanced acetylation of alpha-tubulin in influenza A virus infected epithelial cells. FEBS Lett.585 (1), 128–132 (2011).
- Husain M , CheungCY. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules. J. Virol.88 (19), 11229–11239 (2014).
- Mai A , RotiliD, MassaSet al. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. Bioorg. Med. Chem. Lett.17 (5), 1221–1225 (2007).
- Simonetti G , PassarielloC, RotiliD, MaiA, GaraciE, PalamaraAT. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res.7 (8), 1371–1380 (2007).
- Mai A , MassaS, PezziRet al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J. Med. Chem.48 (9), 3344–3353 (2005).
- Inoue S , MaiA, DyerMJS, CohenGM. Inhibition of histone deacetylase Class I but not Class II Is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-induced apoptosis. Cancer Res.66 (13), 6785–6792 (2006).
- Duong V , BretC, AltucciLet al. Specific activity of class II histone deacetylases in human breast cancer cells. Mol. Cancer Res.6 (12), 1908–1119 (2008).
- Scognamiglio A , NebbiosoA, ManzoF, ValenteS, MaiA, AltucciL. HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2. Biochim. Biophys. Acta1783 (10), 2030–2038 (2008).
- Ragno R , SimeoniS, RotiliDet al. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. Eur. J. Med. Chem.43 (3), 621–632 (2008).
- Illi B , Dello RussoC, ColussiCet al. Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ. Res.102 (1), 51–58 (2008).
- Naldi M , CalonghiN, MasottiLet al. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors. Proteomics9 (24), 5437–5445 (2009).
- Nebbioso A , ManzoF, MiceliMet al. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes. EMBO Rep.10 (7), 776–782 (2009).
- Nebbioso A , Dell'AversanaC, BuggeAKet al. HDACs class II selective inhibition alters nuclear receptor dependent differentiation. J. Mol. Endocrinol.45 (4), 219–228 (2010).
- Colussi C , RosatiJ, StrainoSet al. N∊-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc. Natl Acad. Sci. USA108 (7), 2795–2800 (2011).
- Lenoir O , FlosseauK, MaFXet al. Specific control of pancreatic endocrine beta- and delta-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9. Diabetes60 (11), 2861–2871 (2011).
- Palmisano I , Della ChiaraG, D'AmbrosioRLet al. Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4). Proc. Natl Acad. Sci. USA109 (34), E2284–E2293 (2012).
- Mannaerts I , EysackersN, OnyemaOOet al. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS ONE8 (1), e55786 (2013).
- Spallotta F , TardivoS, NanniSet al. Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia. J. Biol. Chem.288 (32), 22915–22929 (2013).
- Momose F , NaitoT, YanoK, SugimotoS, MorikawaY, NagataK. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem.277 (47), 45306–45314 (2002).
- Naito T , MomoseF, KawaguchiA, NagataK. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J. Virol.81 (3), 1339–1349 (2007).
- Amatore D , SgarbantiR, AquilanoKet al. Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS. Cell. Microbiol.17 (1), 131–145 (2015).
- Mahay BWJ . Virology: A Practical Approach. IRL Press, Oxford, UK, 119–150 (1991).
- Lahm A , PaoliniC, PallaoroMet al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl Acad. Sci. USA104, 17335–17340 (2007).
- Bradner JE , WestN, GrachanMLet al. Chemical phylogenetics of histone deacetylases. Nat. Chem. Biol.6, 238–243 (2010).
- Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods65 (1–2), 55–63 (1983).
- Piacentini R , Li PumaDD, RipoliCet al. Herpes simplex virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation. Sci. Rep.5, 15444 (2015).
- Valente S , ConteM, TardugnoMet al. Pyrrole-based hydroxamates and 2-aminoanilides: histone deacetylase inhibition and cellular activities. ChemMedChem4 (9), 1411–1415 (2009).
- Sinisterra JV , MoulounguiZ, DelmasM, GasetA. Barium hydroxide as catalyst in organic reactions. V. Application in the Horner reaction under solid-liquid phase-transfer conditions. Synthesis1985 (12), 1097–1100 (1985).
- Suzuki T , AndoT, TsuchiyaKet al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J. Med. Chem.42 (15), 3001–3003 (1999).
- Butler KV , KalinJ, BrochierC, VistoliG, LangleyB, KozikowskiAP. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J. Am. Chem. Soc.132 (31), 10842–10846 (2010).
- Tai VWF , VernerE, BalasubramanianS, LeeCS, BuggyJJ. WO 2007109178 A3 (2007).
- Khan N , JeffersM, KumarSet al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J.409 (2), 581–589 (2008).
- Spallotta F , RosatiJ, StrainoSet al. Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemia. Stem. Cells28 (3), 431–442 (2010).
- Hildmann C , WegenerD, RiesterDet al. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases. J. Biotechnol.124 (1), 258–270 (2006).
- Balasubramanian S , RamosJ, LuoW, SirisawadM, VernerE, BuggyJJ. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia22 (5), 1026–1034 (2008).
- Scroggins BT , RobzykK, WangDet al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell25 (1), 151–159 (2007).
- Bali P , PranpatM, BradnerJet al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J. Biol. Chem.280 (29), 26729–26734 (2005a).
- Kovacs JJ , MurphyPJ, GaillardSet al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell18, 601–607 (2005).